Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.

Ju UH, Liu FC, Lin CS, Huang WY, Lin TY, Shen CH, Chou YC, Lin CL, Lin KT, Kao CH, Chen CH, Yang TY.

Medicine (Baltimore). 2019 Apr;98(14):e14984. doi: 10.1097/MD.0000000000014984.

2.

Prioritizing Parkinson's disease genes using population-scale transcriptomic data.

Li YI, Wong G, Humphrey J, Raj T.

Nat Commun. 2019 Mar 1;10(1):994. doi: 10.1038/s41467-019-08912-9.

3.

Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.

George G, Valiya Parambath S, Lokappa SB, Varkey J.

Gene. 2019 May 20;697:67-77. doi: 10.1016/j.gene.2019.02.026. Epub 2019 Feb 16.

PMID:
30776463
4.

Association between autonomic dysfunction and olfactory dysfunction in Parkinson's disease in southern Chinese.

Wang XY, Han YY, Li G, Zhang B.

BMC Neurol. 2019 Feb 2;19(1):17. doi: 10.1186/s12883-019-1243-4.

5.

Parkinson's Disease.

Reich SG, Savitt JM.

Med Clin North Am. 2019 Mar;103(2):337-350. doi: 10.1016/j.mcna.2018.10.014. Epub 2018 Dec 3. Review.

PMID:
30704685
6.

Depression symptomatology correlates with event-related potentials in Parkinson's disease: An affective priming study.

Dissanayaka NNW, Au TR, Angwin AJ, Iyer KK, O'Sullivan JD, Byrne GJ, Silburn PA, Marsh R, Mellick GD, Copland DA.

J Affect Disord. 2019 Feb 15;245:897-904. doi: 10.1016/j.jad.2018.11.094. Epub 2018 Nov 13.

PMID:
30699874
7.

Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).

Włodarek D.

Nutrients. 2019 Jan 15;11(1). pii: E169. doi: 10.3390/nu11010169. Review.

8.

COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.

Wang YC, Zou YB, Xiao J, Pan CD, Jiang SD, Zheng ZJ, Yan ZR, Tang KY, Tan LM, Tang MS.

Neurol Res. 2019 Apr;41(4):319-325. doi: 10.1080/01616412.2018.1564183. Epub 2019 Jan 15.

PMID:
30644790
9.

A latent allocation model for the analysis of microbial composition and disease.

Abe K, Hirayama M, Ohno K, Shimamura T.

BMC Bioinformatics. 2018 Dec 31;19(Suppl 19):519. doi: 10.1186/s12859-018-2530-6.

10.

Can pimavanserin help patients with Parkinson disease psychosis?

de la Cruz J, Canal C.

JAAPA. 2019 Jan;32(1):44-45. doi: 10.1097/01.JAA.0000547757.46299.3d.

PMID:
30589736
11.

Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson's Disease.

Matsubara T, Suzuki K, Fujita H, Watanabe Y, Sakuramoto H, Matsubara M, Hirata K.

Eur Neurol. 2018;80(3-4):193-199. doi: 10.1159/000495797. Epub 2018 Dec 20.

PMID:
30572329
12.

Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back.

De Lazzari F, Bisaglia M, Zordan MA, Sandrelli F.

Int J Mol Sci. 2018 Dec 6;19(12). pii: E3911. doi: 10.3390/ijms19123911. Review.

13.

miR-486-3p Influences the Neurotoxicity of a-Synuclein by Targeting the SIRT2 Gene and the Polymorphisms at Target Sites Contributing to Parkinson's Disease.

Wang Y, Cai Y, Huang H, Chen X, Chen X, Chen X, Mai H, Li X, Zhao J, Yang J, Fan W, Tang P, Chen Y, Li K, Cui L.

Cell Physiol Biochem. 2018;51(6):2732-2745. doi: 10.1159/000495963. Epub 2018 Dec 12.

14.

Non-motor predictors of freezing of gait in Parkinson's disease.

Banks SJ, Bayram E, Shan G, LaBelle DR, Bluett B.

Gait Posture. 2019 Feb;68:311-316. doi: 10.1016/j.gaitpost.2018.12.009. Epub 2018 Dec 6.

PMID:
30553992
15.

Being caregiver of people with Parkinson's Disease: experienced situations.

Padovani C, Lopes MCL, Higahashi IH, Pelloso SM, Paiano M, Christophoro R.

Rev Bras Enferm. 2018;71(suppl 6):2628-2634. doi: 10.1590/0034-7167-2017-0008. English, Portuguese.

16.

Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease.

Liu CF, Wang T, Zhan SQ, Geng DQ, Wang J, Liu J, Shang HF, Wang LJ, Chan P, Chen HB, Chen SD, Wang YP, Zhao ZX, Chaudhuri KR.

Chin Med J (Engl). 2018 Dec 20;131(24):2976-2985. doi: 10.4103/0366-6999.247210. No abstract available.

17.

MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson's Disease by Binding to AXIN1.

Zhou L, Yang L, Li YJ, Mei R, Yu HL, Gong Y, Du MY, Wang F.

Cell Physiol Biochem. 2018;51(5):2275-2289. doi: 10.1159/000495872. Epub 2018 Dec 7.

18.

LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.

Hu D, Niu JY, Xiong J, Nie SK, Zeng F, Zhang ZH.

Curr Med Sci. 2018 Dec;38(6):1012-1017. doi: 10.1007/s11596-018-1977-z. Epub 2018 Dec 7.

PMID:
30536063
20.

Parkinson disease.

Kim SD, Allen NE, Canning CG, Fung VSC.

Handb Clin Neurol. 2018;159:173-193. doi: 10.1016/B978-0-444-63916-5.00011-2. Review.

PMID:
30482313

Supplemental Content

Loading ...
Support Center